VistaShares Artificial Intelligence Supercycle ETF(AIS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AIS VistaShares Artificial Intelligence Supercycle ETF

盘前交易 12-29 07:37:48 EST

38.11

+0.19

+0.49%

最高38.11	最低37.90	成交量2.81万
今开38.10	昨收37.92	日振幅0.54%
总市值1.02亿	流通市值1.02亿	总股本267.50万
成交额106.82万	换手率1.05%	流通股本267.50万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AIS","market":"US","secType":"STK","nameCN":"VistaShares Artificial Intelligence Supercycle ETF","latestPrice":38.105,"timestamp":1766782800000,"preClose":37.92,"halted":0,"volume":28087,"delay":0,"floatShares":2675000,"shares":2675000,"eps":0,"marketStatus":"盘前交易","change":0.185,"latestTime":"12-29 07:37:48 EST","open":38.1,"high":38.105,"low":37.9,"amount":1068226.5795119999,"amplitude":0.005406,"askPrice":41.78,"askSize":100,"bidPrice":35,"bidSize":3,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767018600000},"marketStatusCode":1,"adr":0,"exchange":"AMEX","adjPreClose":38.105,"sharesOutstanding":2675000,"nav":37.86,"aum":101275500,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":38.11,"preClose":38.105,"latestTime":"18:17 EST","volume":317,"amount":12078.608,"timestamp":1766791028732},"volumeRatio":0.6508882597367638,"impliedVol":0.1234,"impliedVolPercentile":0.6111},"requestUrl":"/m/hq/s/AIS","defaultTab":"news","newsList":[{"id":"2594257979","title":"辽冀联合开展交界水域渔业安全执法行动","url":"https://stock-news.laohu8.com/highlight/detail?id=2594257979","media":"北国网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594257979?lang=zh_cn&edition=full","pubTime":"2025-12-26 08:54","pubTimestamp":1766710440,"startTime":"0","endTime":"0","summary":"本报讯记者胡海林报道为打击各类渔业违法违规行为，防范化解海上安全风险，维护重点海域渔业生产秩序稳定，12月起，省海洋与渔业行政执法总队联合河北省海洋渔政执法总队，在辽冀交界水域组织开展渔业安全海上联合执法行动。　　行动中，辽冀两省执法力量密切配合、协同作战，查扣涉嫌违规渔船3艘。目前，涉案渔船已全部被依法立案调查，案件正在进一步办理中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-12-26/doc-inheaqmt2893092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AIS"],"gpt_icon":0},{"id":"2570846925","title":"重磅！NMPA批准普佑克新增急性缺血性脑卒中适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2570846925","media":"医药地理","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570846925?lang=zh_cn&edition=full","pubTime":"2025-09-28 17:09","pubTimestamp":1759050540,"startTime":"0","endTime":"0","summary":"近日，天士力生物宣布收到国家药监局批准文件，其自主研发的生物创新药注射用重组人尿激酶原新增急性缺血性脑卒中溶栓治疗适应症。急性缺血性脑卒中是中国居民致残和致死的主要病因之一，每年新发病例约200万，其中约占卒中总发病数的80%。随着普佑克脑梗适应症的落地，以及多款生物创新药逐步进入临床中后期，天士力在急危重症和治疗难度大的疾病领域形成“中药+生物药”双轮驱动的研发格局。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-09-28/doc-infrzuip4345784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AIS"],"gpt_icon":0},{"id":"2564824111","title":"大行评级｜中银国际：上调比亚迪电子目标价至52.2港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2564824111","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564824111?lang=zh_cn&edition=full","pubTime":"2025-09-02 10:42","pubTimestamp":1756780932,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0823421333.USD","LU1934455863.HKD","LU0353189763.USD","LU0476273544.USD","LU2168564149.EUR","LU0528227936.USD","LU0320765059.SGD","BK4553","LU1066051225.USD","LU2236285917.USD","HK0000306685.HKD","LU1244550221.USD","AAPL","LU0823421416.USD","IE0004445015.USD","00285","LU2860962120.EUR","AIS","SG9999015358.SGD","LU1366333091.USD","LU2023250504.SGD","LU0985320562.USD","LU1629891620.HKD","LU1823568750.SGD","LU0096362180.USD","LU1815336760.USD","LU0082616367.USD","LU0494093205.USD","MACW.SI","LU1732799900.SGD","SG9999014559.SGD","LU1316542783.SGD","LU0820561909.HKD","LU0511384066.AUD","LU2054465674.USD","LU1232071149.USD","LU0949170772.SGD","SG9999014542.SGD","LU2552382132.HKD","LU0210528500.USD","LU2213496289.HKD","LU1037948541.HKD","LU0348723411.USD","N0Z.SI","LU1496350502.SGD","IE00B775SV38.USD","LU0316494557.USD","LU1582986433.USD","LU1291159041.SGD","LU0661504455.SGD"],"gpt_icon":0},{"id":"2549515905","title":"数据赋能破局 浙江宁波激活产业发展“新动能”","url":"https://stock-news.laohu8.com/highlight/detail?id=2549515905","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549515905?lang=zh_cn&edition=full","pubTime":"2025-07-08 15:46","pubTimestamp":1751960760,"startTime":"0","endTime":"0","summary":"宁波市数据局供图数据要素正成为宁波产业升级的“金钥匙”。在宁波市数据局统筹下，一系列公共数据开发应用场景落地生根，为经济高质量发展注入新动能。江北区“能效洞察者”平台堪称企业“节能管家”。外贸企业也因数据联动迎来新机遇。从港口物流到智能制造，从跨境贸易到医疗服务，宁波市数据局通过构建“数据归集—治理—应用”全链条机制，打破部门壁垒，让数据要素在产业血管中高效流动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-07-08/doc-infetywm5237073.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-07-08/doc-infetywm5237073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AIS"],"gpt_icon":0},{"id":"2501745115","title":"中国境内首个用于男性的HPV疫苗来了！这个年龄段可接种","url":"https://stock-news.laohu8.com/highlight/detail?id=2501745115","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501745115?lang=zh_cn&edition=full","pubTime":"2025-01-08 17:22","pubTimestamp":1736328130,"startTime":"0","endTime":"0","summary":"【中国境内首个用于男性的HPV疫苗来了！这个年龄段可接种】1月8日，默沙东宣布，四价人乳头瘤病毒（HPV）疫苗（商品名：佳达修）的多项新适应症已获得国家药品监督管理局的上市批准，适用于9岁至26岁男性接种。新适应症的获批，标志着佳达修成为中国境内首个且目前唯一获批、可适用于男性的HPV疫苗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202501083291311312.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202501083291311312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4161","AIN","AIS"],"gpt_icon":0},{"id":"2492140964","title":"三省（区）海事航保融通“破圈”激活北部湾发展一盘棋","url":"https://stock-news.laohu8.com/highlight/detail?id=2492140964","media":"媒体滚动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492140964?lang=zh_cn&edition=full","pubTime":"2024-12-19 18:24","pubTimestamp":1734603840,"startTime":"0","endTime":"0","summary":"联防联控筑牢安全屏障为提升北部湾水域海上交通安全风险管控水平，三地海事及航保部门携手制定了北部湾水域预警预控一体化工作机制。针对北部湾水域组织开展的巡航执法活动，制定了北部湾巡航一体化工作机制。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-12-19/doc-inczyxct6805491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AIS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.antarespharma.com","stockEarnings":[{"period":"1week","weight":0.0346},{"period":"1month","weight":0.0552},{"period":"3month","weight":0.111},{"period":"6month","weight":0.3644},{"period":"1year","weight":0.5293},{"period":"ytd","weight":0.5975}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":0.0156},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1226},{"period":"1year","weight":0.148},{"period":"ytd","weight":0.1778}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Antares Pharma, Inc.是一家新兴的制药公司，专注于自我注射药物产品和技术，以及外用凝胶产品。该公司的皮下和肌肉注射的技术平台包括Vibex一次性压力辅助自动进样器，可重复使用的视觉无针注射器和一次性多采用笔型注射器。该公司利用其在药物传递系统上的经验，提升产品的性能，并开发新药。该公司目前的产品包括一次性使用压力辅助自动喷射系统（Vibex）;一次性笔喷射系统;可重复使用的无针注射系统（Vision）和透皮高级ATD凝胶。","exchange":"AMEX","name":"VistaShares Artificial Intelligence Supercycle ETF","nameEN":"VistaShares Artificial Intelligence Supercycle ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VistaShares Artificial Intelligence Supercycle ETF(AIS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供VistaShares Artificial Intelligence Supercycle ETF(AIS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"VistaShares Artificial Intelligence Supercycle ETF,AIS,VistaShares Artificial Intelligence Supercycle ETF股票,VistaShares Artificial Intelligence Supercycle ETF股票老虎,VistaShares Artificial Intelligence Supercycle ETF股票老虎国际,VistaShares Artificial Intelligence Supercycle ETF行情,VistaShares Artificial Intelligence Supercycle ETF股票行情,VistaShares Artificial Intelligence Supercycle ETF股价,VistaShares Artificial Intelligence Supercycle ETF股市,VistaShares Artificial Intelligence Supercycle ETF股票价格,VistaShares Artificial Intelligence Supercycle ETF股票交易,VistaShares Artificial Intelligence Supercycle ETF股票购买,VistaShares Artificial Intelligence Supercycle ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VistaShares Artificial Intelligence Supercycle ETF(AIS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供VistaShares Artificial Intelligence Supercycle ETF(AIS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}